nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—SLCO1B1—Pazopanib—kidney cancer	0.149	0.233	CbGbCtD
Repaglinide—CYP3A4—Everolimus—kidney cancer	0.0723	0.113	CbGbCtD
Repaglinide—CYP2C8—Pazopanib—kidney cancer	0.0633	0.0986	CbGbCtD
Repaglinide—ALB—Erlotinib—kidney cancer	0.0584	0.0911	CbGbCtD
Repaglinide—CYP3A4—Temsirolimus—kidney cancer	0.0488	0.0762	CbGbCtD
Repaglinide—CYP2C8—Erlotinib—kidney cancer	0.0451	0.0704	CbGbCtD
Repaglinide—CYP2C8—Paclitaxel—kidney cancer	0.0413	0.0644	CbGbCtD
Repaglinide—CYP2C8—Sorafenib—kidney cancer	0.0367	0.0572	CbGbCtD
Repaglinide—CYP3A4—Pazopanib—kidney cancer	0.0257	0.04	CbGbCtD
Repaglinide—CYP3A4—Erlotinib—kidney cancer	0.0183	0.0285	CbGbCtD
Repaglinide—CYP3A4—Paclitaxel—kidney cancer	0.0168	0.0261	CbGbCtD
Repaglinide—CYP3A4—Sorafenib—kidney cancer	0.0149	0.0232	CbGbCtD
Repaglinide—CYP3A4—Vinblastine—kidney cancer	0.0147	0.0229	CbGbCtD
Repaglinide—CYP3A4—Vincristine—kidney cancer	0.0145	0.0225	CbGbCtD
Repaglinide—CYP3A4—Sunitinib—kidney cancer	0.0121	0.0188	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—kidney cancer	0.00903	0.0141	CbGbCtD
Repaglinide—PPARG—Everolimus—Temsirolimus—kidney cancer	0.00474	1	CbGdCrCtD
Repaglinide—PPARG—nephron—kidney cancer	0.00436	0.32	CbGeAlD
Repaglinide—CYP3A4—urine—kidney cancer	0.00156	0.115	CbGeAlD
Repaglinide—ABCC8—renal system—kidney cancer	0.00112	0.0823	CbGeAlD
Repaglinide—ABCC8—kidney—kidney cancer	0.00108	0.0795	CbGeAlD
Repaglinide—SLCO1B1—renal system—kidney cancer	0.000992	0.0728	CbGeAlD
Repaglinide—SLCO1B1—kidney—kidney cancer	0.000959	0.0704	CbGeAlD
Repaglinide—PPARG—renal system—kidney cancer	0.000856	0.0628	CbGeAlD
Repaglinide—PPARG—kidney—kidney cancer	0.000827	0.0607	CbGeAlD
Repaglinide—CYP2C8—renal system—kidney cancer	0.000564	0.0414	CbGeAlD
Repaglinide—CYP2C8—kidney—kidney cancer	0.000545	0.04	CbGeAlD
Repaglinide—Gastrointestinal pain—Vinblastine—kidney cancer	0.000464	0.00175	CcSEcCtD
Repaglinide—Thrombocytopenia—Sunitinib—kidney cancer	0.000463	0.00174	CcSEcCtD
Repaglinide—Gastrointestinal pain—Everolimus—kidney cancer	0.000463	0.00174	CcSEcCtD
Repaglinide—Skin disorder—Sunitinib—kidney cancer	0.000459	0.00173	CcSEcCtD
Repaglinide—Vomiting—Pazopanib—kidney cancer	0.000455	0.00172	CcSEcCtD
Repaglinide—Rash—Pazopanib—kidney cancer	0.000452	0.0017	CcSEcCtD
Repaglinide—Nausea—Temsirolimus—kidney cancer	0.000452	0.0017	CcSEcCtD
Repaglinide—Dermatitis—Pazopanib—kidney cancer	0.000451	0.0017	CcSEcCtD
Repaglinide—Back pain—Gemcitabine—kidney cancer	0.000449	0.00169	CcSEcCtD
Repaglinide—Abdominal pain—Vinblastine—kidney cancer	0.000449	0.00169	CcSEcCtD
Repaglinide—Headache—Pazopanib—kidney cancer	0.000449	0.00169	CcSEcCtD
Repaglinide—Rhinitis—Paclitaxel—kidney cancer	0.000448	0.00169	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000447	0.00168	CcSEcCtD
Repaglinide—Oedema—Dactinomycin—kidney cancer	0.000447	0.00168	CcSEcCtD
Repaglinide—Abdominal pain—Everolimus—kidney cancer	0.000447	0.00168	CcSEcCtD
Repaglinide—Gastrointestinal pain—Erlotinib—kidney cancer	0.000446	0.00168	CcSEcCtD
Repaglinide—Angina pectoris—Capecitabine—kidney cancer	0.000446	0.00168	CcSEcCtD
Repaglinide—Bronchitis—Capecitabine—kidney cancer	0.000441	0.00166	CcSEcCtD
Repaglinide—Oedema peripheral—Paclitaxel—kidney cancer	0.00044	0.00166	CcSEcCtD
Repaglinide—Leukopenia—Vincristine—kidney cancer	0.000438	0.00165	CcSEcCtD
Repaglinide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000438	0.00165	CcSEcCtD
Repaglinide—Dyspepsia—Sorafenib—kidney cancer	0.000432	0.00163	CcSEcCtD
Repaglinide—Abdominal pain—Erlotinib—kidney cancer	0.000431	0.00162	CcSEcCtD
Repaglinide—Visual impairment—Paclitaxel—kidney cancer	0.000431	0.00162	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00043	0.00162	CcSEcCtD
Repaglinide—Nausea—Pazopanib—kidney cancer	0.000426	0.0016	CcSEcCtD
Repaglinide—Paraesthesia—Sunitinib—kidney cancer	0.000424	0.0016	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000424	0.0016	CcSEcCtD
Repaglinide—Hypertension—Vincristine—kidney cancer	0.000423	0.00159	CcSEcCtD
Repaglinide—Erythema multiforme—Paclitaxel—kidney cancer	0.000422	0.00159	CcSEcCtD
Repaglinide—Constipation—Sorafenib—kidney cancer	0.00042	0.00158	CcSEcCtD
Repaglinide—Hypersensitivity—Vinblastine—kidney cancer	0.000418	0.00158	CcSEcCtD
Repaglinide—Eye disorder—Paclitaxel—kidney cancer	0.000418	0.00157	CcSEcCtD
Repaglinide—Hypersensitivity—Everolimus—kidney cancer	0.000417	0.00157	CcSEcCtD
Repaglinide—Dyspepsia—Sunitinib—kidney cancer	0.000416	0.00157	CcSEcCtD
Repaglinide—Leukopenia—Gemcitabine—kidney cancer	0.000416	0.00157	CcSEcCtD
Repaglinide—Cardiac disorder—Paclitaxel—kidney cancer	0.000415	0.00156	CcSEcCtD
Repaglinide—Hyperglycaemia—Capecitabine—kidney cancer	0.000413	0.00156	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000408	0.00154	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000407	0.00153	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000405	0.00152	CcSEcCtD
Repaglinide—Constipation—Sunitinib—kidney cancer	0.000404	0.00152	CcSEcCtD
Repaglinide—Immune system disorder—Paclitaxel—kidney cancer	0.000404	0.00152	CcSEcCtD
Repaglinide—Acute coronary syndrome—Capecitabine—kidney cancer	0.000403	0.00152	CcSEcCtD
Repaglinide—Gastrointestinal pain—Sorafenib—kidney cancer	0.000402	0.00151	CcSEcCtD
Repaglinide—Hypertension—Gemcitabine—kidney cancer	0.000401	0.00151	CcSEcCtD
Repaglinide—Myocardial infarction—Capecitabine—kidney cancer	0.0004	0.00151	CcSEcCtD
Repaglinide—Pruritus—Everolimus—kidney cancer	0.0004	0.00151	CcSEcCtD
Repaglinide—Anaphylactic shock—Vincristine—kidney cancer	0.0004	0.0015	CcSEcCtD
Repaglinide—Oedema—Vincristine—kidney cancer	0.0004	0.0015	CcSEcCtD
Repaglinide—Arrhythmia—Paclitaxel—kidney cancer	0.000399	0.0015	CcSEcCtD
Repaglinide—Jaundice—Capecitabine—kidney cancer	0.000398	0.0015	CcSEcCtD
Repaglinide—Urinary tract infection—Capecitabine—kidney cancer	0.000397	0.0015	CcSEcCtD
Repaglinide—Arthralgia—Gemcitabine—kidney cancer	0.000395	0.00149	CcSEcCtD
Repaglinide—Chest pain—Gemcitabine—kidney cancer	0.000395	0.00149	CcSEcCtD
Repaglinide—Alopecia—Paclitaxel—kidney cancer	0.000395	0.00149	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000393	0.00148	CcSEcCtD
Repaglinide—Thrombocytopenia—Vincristine—kidney cancer	0.000391	0.00147	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000391	0.00147	CcSEcCtD
Repaglinide—Urticaria—Sorafenib—kidney cancer	0.00039	0.00147	CcSEcCtD
Repaglinide—Malnutrition—Paclitaxel—kidney cancer	0.000389	0.00146	CcSEcCtD
Repaglinide—Erythema—Paclitaxel—kidney cancer	0.000389	0.00146	CcSEcCtD
Repaglinide—Diarrhoea—Vinblastine—kidney cancer	0.000389	0.00146	CcSEcCtD
Repaglinide—Abdominal pain—Sorafenib—kidney cancer	0.000388	0.00146	CcSEcCtD
Repaglinide—Diarrhoea—Everolimus—kidney cancer	0.000387	0.00146	CcSEcCtD
Repaglinide—Gastrointestinal pain—Sunitinib—kidney cancer	0.000386	0.00145	CcSEcCtD
Repaglinide—Hepatobiliary disease—Capecitabine—kidney cancer	0.000386	0.00145	CcSEcCtD
Repaglinide—Pruritus—Erlotinib—kidney cancer	0.000386	0.00145	CcSEcCtD
Repaglinide—CYP3A4—renal system—kidney cancer	0.000382	0.028	CbGeAlD
Repaglinide—Anaphylactic shock—Gemcitabine—kidney cancer	0.000379	0.00143	CcSEcCtD
Repaglinide—Oedema—Gemcitabine—kidney cancer	0.000379	0.00143	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000377	0.00142	CcSEcCtD
Repaglinide—Back pain—Paclitaxel—kidney cancer	0.000376	0.00142	CcSEcCtD
Repaglinide—Abdominal pain—Sunitinib—kidney cancer	0.000373	0.00141	CcSEcCtD
Repaglinide—Diarrhoea—Erlotinib—kidney cancer	0.000373	0.00141	CcSEcCtD
Repaglinide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000371	0.0014	CcSEcCtD
Repaglinide—CYP3A4—kidney—kidney cancer	0.000369	0.0271	CbGeAlD
Repaglinide—Skin disorder—Gemcitabine—kidney cancer	0.000368	0.00139	CcSEcCtD
Repaglinide—Rhinitis—Capecitabine—kidney cancer	0.000368	0.00138	CcSEcCtD
Repaglinide—Hepatitis—Capecitabine—kidney cancer	0.000367	0.00138	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000366	0.00138	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000364	0.00137	CcSEcCtD
Repaglinide—Hypersensitivity—Sorafenib—kidney cancer	0.000362	0.00136	CcSEcCtD
Repaglinide—Oedema peripheral—Capecitabine—kidney cancer	0.000361	0.00136	CcSEcCtD
Repaglinide—Vomiting—Vinblastine—kidney cancer	0.000361	0.00136	CcSEcCtD
Repaglinide—Vomiting—Everolimus—kidney cancer	0.00036	0.00135	CcSEcCtD
Repaglinide—Paraesthesia—Vincristine—kidney cancer	0.000359	0.00135	CcSEcCtD
Repaglinide—Rash—Everolimus—kidney cancer	0.000357	0.00134	CcSEcCtD
Repaglinide—Dermatitis—Everolimus—kidney cancer	0.000356	0.00134	CcSEcCtD
Repaglinide—Headache—Vinblastine—kidney cancer	0.000356	0.00134	CcSEcCtD
Repaglinide—Headache—Everolimus—kidney cancer	0.000354	0.00133	CcSEcCtD
Repaglinide—Abdominal pain—Dactinomycin—kidney cancer	0.000354	0.00133	CcSEcCtD
Repaglinide—Visual impairment—Capecitabine—kidney cancer	0.000353	0.00133	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000353	0.00133	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—kidney cancer	0.00035	0.00132	CcSEcCtD
Repaglinide—Leukopenia—Paclitaxel—kidney cancer	0.000348	0.00131	CcSEcCtD
Repaglinide—Hypersensitivity—Sunitinib—kidney cancer	0.000348	0.00131	CcSEcCtD
Repaglinide—Pruritus—Sorafenib—kidney cancer	0.000347	0.00131	CcSEcCtD
Repaglinide—Vomiting—Erlotinib—kidney cancer	0.000347	0.00131	CcSEcCtD
Repaglinide—Erythema multiforme—Capecitabine—kidney cancer	0.000347	0.00131	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000345	0.0013	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000345	0.0013	CcSEcCtD
Repaglinide—Rash—Erlotinib—kidney cancer	0.000344	0.0013	CcSEcCtD
Repaglinide—Dermatitis—Erlotinib—kidney cancer	0.000344	0.00129	CcSEcCtD
Repaglinide—Palpitations—Paclitaxel—kidney cancer	0.000344	0.00129	CcSEcCtD
Repaglinide—Eye disorder—Capecitabine—kidney cancer	0.000343	0.00129	CcSEcCtD
Repaglinide—Headache—Erlotinib—kidney cancer	0.000342	0.00129	CcSEcCtD
Repaglinide—Constipation—Vincristine—kidney cancer	0.000342	0.00129	CcSEcCtD
Repaglinide—Paraesthesia—Gemcitabine—kidney cancer	0.00034	0.00128	CcSEcCtD
Repaglinide—Cardiac disorder—Capecitabine—kidney cancer	0.00034	0.00128	CcSEcCtD
Repaglinide—Nausea—Vinblastine—kidney cancer	0.000337	0.00127	CcSEcCtD
Repaglinide—Nausea—Everolimus—kidney cancer	0.000336	0.00127	CcSEcCtD
Repaglinide—Diarrhoea—Sorafenib—kidney cancer	0.000336	0.00127	CcSEcCtD
Repaglinide—Hypertension—Paclitaxel—kidney cancer	0.000336	0.00126	CcSEcCtD
Repaglinide—Pruritus—Sunitinib—kidney cancer	0.000334	0.00126	CcSEcCtD
Repaglinide—Immune system disorder—Capecitabine—kidney cancer	0.000331	0.00125	CcSEcCtD
Repaglinide—Arthralgia—Paclitaxel—kidney cancer	0.000331	0.00125	CcSEcCtD
Repaglinide—Chest pain—Paclitaxel—kidney cancer	0.000331	0.00125	CcSEcCtD
Repaglinide—Hypersensitivity—Dactinomycin—kidney cancer	0.00033	0.00124	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000329	0.00124	CcSEcCtD
Repaglinide—Arrhythmia—Capecitabine—kidney cancer	0.000328	0.00123	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000327	0.00123	CcSEcCtD
Repaglinide—Gastrointestinal pain—Vincristine—kidney cancer	0.000327	0.00123	CcSEcCtD
Repaglinide—Constipation—Gemcitabine—kidney cancer	0.000324	0.00122	CcSEcCtD
Repaglinide—Nausea—Erlotinib—kidney cancer	0.000324	0.00122	CcSEcCtD
Repaglinide—Alopecia—Capecitabine—kidney cancer	0.000324	0.00122	CcSEcCtD
Repaglinide—Diarrhoea—Sunitinib—kidney cancer	0.000323	0.00122	CcSEcCtD
Repaglinide—Erythema—Capecitabine—kidney cancer	0.000319	0.0012	CcSEcCtD
Repaglinide—Malnutrition—Capecitabine—kidney cancer	0.000319	0.0012	CcSEcCtD
Repaglinide—Oedema—Paclitaxel—kidney cancer	0.000317	0.0012	CcSEcCtD
Repaglinide—Anaphylactic shock—Paclitaxel—kidney cancer	0.000317	0.0012	CcSEcCtD
Repaglinide—Abdominal pain—Vincristine—kidney cancer	0.000316	0.00119	CcSEcCtD
Repaglinide—Vomiting—Sorafenib—kidney cancer	0.000312	0.00118	CcSEcCtD
Repaglinide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000311	0.00117	CcSEcCtD
Repaglinide—Rash—Sorafenib—kidney cancer	0.00031	0.00117	CcSEcCtD
Repaglinide—Dermatitis—Sorafenib—kidney cancer	0.000309	0.00116	CcSEcCtD
Repaglinide—Back pain—Capecitabine—kidney cancer	0.000309	0.00116	CcSEcCtD
Repaglinide—Skin disorder—Paclitaxel—kidney cancer	0.000308	0.00116	CcSEcCtD
Repaglinide—Headache—Sorafenib—kidney cancer	0.000308	0.00116	CcSEcCtD
Repaglinide—Diarrhoea—Dactinomycin—kidney cancer	0.000306	0.00115	CcSEcCtD
Repaglinide—Vomiting—Sunitinib—kidney cancer	0.0003	0.00113	CcSEcCtD
Repaglinide—Rash—Sunitinib—kidney cancer	0.000298	0.00112	CcSEcCtD
Repaglinide—Dermatitis—Sunitinib—kidney cancer	0.000298	0.00112	CcSEcCtD
Repaglinide—Headache—Sunitinib—kidney cancer	0.000296	0.00111	CcSEcCtD
Repaglinide—Hypersensitivity—Vincristine—kidney cancer	0.000294	0.00111	CcSEcCtD
Repaglinide—Nausea—Sorafenib—kidney cancer	0.000292	0.0011	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—kidney cancer	0.000289	0.00109	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000289	0.00109	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—kidney cancer	0.000288	0.00108	CcSEcCtD
Repaglinide—Leukopenia—Capecitabine—kidney cancer	0.000286	0.00108	CcSEcCtD
Repaglinide—Paraesthesia—Paclitaxel—kidney cancer	0.000285	0.00107	CcSEcCtD
Repaglinide—Vomiting—Dactinomycin—kidney cancer	0.000284	0.00107	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—kidney cancer	0.000284	0.00107	CcSEcCtD
Repaglinide—Palpitations—Capecitabine—kidney cancer	0.000282	0.00106	CcSEcCtD
Repaglinide—Rash—Dactinomycin—kidney cancer	0.000282	0.00106	CcSEcCtD
Repaglinide—Nausea—Sunitinib—kidney cancer	0.000281	0.00106	CcSEcCtD
Repaglinide—Dyspepsia—Paclitaxel—kidney cancer	0.000279	0.00105	CcSEcCtD
Repaglinide—Hypertension—Capecitabine—kidney cancer	0.000276	0.00104	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000274	0.00103	CcSEcCtD
Repaglinide—Diarrhoea—Vincristine—kidney cancer	0.000273	0.00103	CcSEcCtD
Repaglinide—Arthralgia—Capecitabine—kidney cancer	0.000272	0.00102	CcSEcCtD
Repaglinide—Chest pain—Capecitabine—kidney cancer	0.000272	0.00102	CcSEcCtD
Repaglinide—Constipation—Paclitaxel—kidney cancer	0.000271	0.00102	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00027	0.00102	CcSEcCtD
Repaglinide—Pruritus—Gemcitabine—kidney cancer	0.000268	0.00101	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000266	0.001	CcSEcCtD
Repaglinide—Nausea—Dactinomycin—kidney cancer	0.000266	0.001	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000261	0.000983	CcSEcCtD
Repaglinide—Oedema—Capecitabine—kidney cancer	0.00026	0.000981	CcSEcCtD
Repaglinide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00026	0.000977	CcSEcCtD
Repaglinide—Diarrhoea—Gemcitabine—kidney cancer	0.000259	0.000977	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—kidney cancer	0.000257	0.000966	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—kidney cancer	0.000256	0.000964	CcSEcCtD
Repaglinide—Thrombocytopenia—Capecitabine—kidney cancer	0.000255	0.00096	CcSEcCtD
Repaglinide—Vomiting—Vincristine—kidney cancer	0.000254	0.000957	CcSEcCtD
Repaglinide—Skin disorder—Capecitabine—kidney cancer	0.000253	0.000953	CcSEcCtD
Repaglinide—Urticaria—Paclitaxel—kidney cancer	0.000252	0.00095	CcSEcCtD
Repaglinide—Rash—Vincristine—kidney cancer	0.000252	0.000949	CcSEcCtD
Repaglinide—Dermatitis—Vincristine—kidney cancer	0.000252	0.000948	CcSEcCtD
Repaglinide—Abdominal pain—Paclitaxel—kidney cancer	0.000251	0.000945	CcSEcCtD
Repaglinide—Headache—Vincristine—kidney cancer	0.00025	0.000943	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000249	0.000938	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—kidney cancer	0.000247	0.00093	CcSEcCtD
Repaglinide—Vomiting—Gemcitabine—kidney cancer	0.000241	0.000908	CcSEcCtD
Repaglinide—Rash—Gemcitabine—kidney cancer	0.000239	0.0009	CcSEcCtD
Repaglinide—Dermatitis—Gemcitabine—kidney cancer	0.000239	0.000899	CcSEcCtD
Repaglinide—Headache—Gemcitabine—kidney cancer	0.000237	0.000894	CcSEcCtD
Repaglinide—Nausea—Vincristine—kidney cancer	0.000237	0.000894	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000237	0.000894	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—kidney cancer	0.000237	0.000892	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—kidney cancer	0.000236	0.00089	CcSEcCtD
Repaglinide—Paraesthesia—Capecitabine—kidney cancer	0.000234	0.000881	CcSEcCtD
Repaglinide—Hypersensitivity—Paclitaxel—kidney cancer	0.000234	0.000881	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—kidney cancer	0.000233	0.000877	CcSEcCtD
Repaglinide—Dyspepsia—Capecitabine—kidney cancer	0.000229	0.000863	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—kidney cancer	0.000228	0.000858	CcSEcCtD
Repaglinide—Nausea—Gemcitabine—kidney cancer	0.000225	0.000848	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000225	0.000847	CcSEcCtD
Repaglinide—Pruritus—Paclitaxel—kidney cancer	0.000225	0.000846	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—kidney cancer	0.000223	0.000842	CcSEcCtD
Repaglinide—Constipation—Capecitabine—kidney cancer	0.000223	0.000839	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—kidney cancer	0.000221	0.000832	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—kidney cancer	0.000219	0.000826	CcSEcCtD
Repaglinide—Diarrhoea—Paclitaxel—kidney cancer	0.000217	0.000818	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—kidney cancer	0.000213	0.000804	CcSEcCtD
Repaglinide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000213	0.000802	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—kidney cancer	0.000211	0.000795	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—kidney cancer	0.000209	0.000786	CcSEcCtD
Repaglinide—Urticaria—Capecitabine—kidney cancer	0.000207	0.000779	CcSEcCtD
Repaglinide—Abdominal pain—Capecitabine—kidney cancer	0.000206	0.000775	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—kidney cancer	0.000206	0.000775	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—kidney cancer	0.000206	0.000775	CcSEcCtD
Repaglinide—Vomiting—Paclitaxel—kidney cancer	0.000202	0.00076	CcSEcCtD
Repaglinide—Rash—Paclitaxel—kidney cancer	0.0002	0.000754	CcSEcCtD
Repaglinide—Dermatitis—Paclitaxel—kidney cancer	0.0002	0.000753	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—kidney cancer	0.000199	0.000749	CcSEcCtD
Repaglinide—Headache—Paclitaxel—kidney cancer	0.000199	0.000749	CcSEcCtD
Repaglinide—Hypersensitivity—Capecitabine—kidney cancer	0.000192	0.000723	CcSEcCtD
Repaglinide—Nausea—Paclitaxel—kidney cancer	0.000189	0.00071	CcSEcCtD
Repaglinide—Pruritus—Capecitabine—kidney cancer	0.000184	0.000694	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—kidney cancer	0.000184	0.000694	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—kidney cancer	0.000182	0.000685	CcSEcCtD
Repaglinide—Diarrhoea—Capecitabine—kidney cancer	0.000178	0.000671	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—kidney cancer	0.000178	0.000669	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—kidney cancer	0.000175	0.00066	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—kidney cancer	0.000175	0.00066	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000174	0.000655	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—kidney cancer	0.000168	0.000632	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—kidney cancer	0.000168	0.000632	CcSEcCtD
Repaglinide—Vomiting—Capecitabine—kidney cancer	0.000166	0.000624	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000164	0.000619	CcSEcCtD
Repaglinide—Rash—Capecitabine—kidney cancer	0.000164	0.000619	CcSEcCtD
Repaglinide—Dermatitis—Capecitabine—kidney cancer	0.000164	0.000618	CcSEcCtD
Repaglinide—Headache—Capecitabine—kidney cancer	0.000163	0.000615	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—kidney cancer	0.000163	0.000614	CcSEcCtD
Repaglinide—Nausea—Capecitabine—kidney cancer	0.000155	0.000583	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000153	0.000576	CcSEcCtD
Repaglinide—Paraesthesia—Doxorubicin—kidney cancer	0.000151	0.000568	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—kidney cancer	0.000148	0.000557	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000145	0.000546	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—kidney cancer	0.000144	0.000541	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000137	0.000517	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—kidney cancer	0.000133	0.000502	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—kidney cancer	0.000133	0.0005	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—kidney cancer	0.000124	0.000466	CcSEcCtD
Repaglinide—Pruritus—Doxorubicin—kidney cancer	0.000119	0.000447	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—kidney cancer	0.000115	0.000433	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—kidney cancer	0.000107	0.000402	CcSEcCtD
Repaglinide—Rash—Doxorubicin—kidney cancer	0.000106	0.000399	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—kidney cancer	0.000106	0.000398	CcSEcCtD
Repaglinide—Headache—Doxorubicin—kidney cancer	0.000105	0.000396	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—kidney cancer	9.97e-05	0.000376	CcSEcCtD
Repaglinide—ABCC8—Metabolism—PTGS1—kidney cancer	5.51e-05	0.000737	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KDR—kidney cancer	5.44e-05	0.000727	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PGK1—kidney cancer	5.41e-05	0.000724	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC5A3—kidney cancer	5.41e-05	0.000724	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PSMD7—kidney cancer	5.4e-05	0.000722	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SCARB1—kidney cancer	5.4e-05	0.000722	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—EIF4EBP1—kidney cancer	5.36e-05	0.000716	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HSPB1—kidney cancer	5.36e-05	0.000716	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS1—kidney cancer	5.34e-05	0.000714	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MET—kidney cancer	5.32e-05	0.000712	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—LDHB—kidney cancer	5.31e-05	0.00071	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PSMD7—kidney cancer	5.24e-05	0.000701	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITPR2—kidney cancer	5.13e-05	0.000686	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—BCHE—kidney cancer	5.12e-05	0.000685	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—kidney cancer	5.1e-05	0.000682	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.07e-05	0.000678	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC5A5—kidney cancer	5.06e-05	0.000677	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.05e-05	0.000675	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PDHB—kidney cancer	5.03e-05	0.000673	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.02e-05	0.000671	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—POMC—kidney cancer	5.02e-05	0.000671	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PDHB—kidney cancer	5.01e-05	0.000669	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PSMD7—kidney cancer	4.98e-05	0.000666	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CRABP1—kidney cancer	4.97e-05	0.000665	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—BCHE—kidney cancer	4.97e-05	0.000664	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC5A5—kidney cancer	4.91e-05	0.000656	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC2A1—kidney cancer	4.89e-05	0.000653	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC2A1—kidney cancer	4.74e-05	0.000634	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CCBL1—kidney cancer	4.73e-05	0.000633	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CCBL1—kidney cancer	4.71e-05	0.000629	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—RAF1—kidney cancer	4.66e-05	0.000623	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—kidney cancer	4.65e-05	0.000622	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.65e-05	0.000622	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ITPR2—kidney cancer	4.62e-05	0.000618	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CA9—kidney cancer	4.6e-05	0.000615	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.5e-05	0.000602	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—JUNB—kidney cancer	4.47e-05	0.000598	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.28e-05	0.000572	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.26e-05	0.00057	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.26e-05	0.000569	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTT1—kidney cancer	4.21e-05	0.000563	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ACHE—kidney cancer	4.21e-05	0.000563	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.15e-05	0.000555	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPAT—kidney cancer	4.1e-05	0.000549	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GLIPR1—kidney cancer	4.1e-05	0.000549	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.09e-05	0.000547	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GLIPR1—kidney cancer	4.08e-05	0.000546	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPAT—kidney cancer	4.08e-05	0.000546	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTP1—kidney cancer	4.08e-05	0.000545	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.05e-05	0.000542	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.03e-05	0.000539	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.01e-05	0.000536	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.99e-05	0.000533	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SCARB1—kidney cancer	3.99e-05	0.000533	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTP1—kidney cancer	3.95e-05	0.000528	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS1—kidney cancer	3.95e-05	0.000528	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RAF1—kidney cancer	3.93e-05	0.000526	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RELA—kidney cancer	3.92e-05	0.000524	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CRABP1—kidney cancer	3.91e-05	0.000523	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ERBB2—kidney cancer	3.89e-05	0.00052	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PSMD7—kidney cancer	3.87e-05	0.000518	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ABCB1—kidney cancer	3.86e-05	0.000516	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FH—kidney cancer	3.82e-05	0.00051	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APRT—kidney cancer	3.82e-05	0.00051	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.81e-05	0.00051	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FH—kidney cancer	3.79e-05	0.000507	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APRT—kidney cancer	3.79e-05	0.000507	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA1—kidney cancer	3.76e-05	0.000503	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.76e-05	0.000503	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTM1—kidney cancer	3.74e-05	0.000501	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ABCB1—kidney cancer	3.74e-05	0.0005	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.73e-05	0.000499	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.71e-05	0.000496	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—BCHE—kidney cancer	3.67e-05	0.000491	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—CDKN2B—kidney cancer	3.64e-05	0.000487	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ITPR2—kidney cancer	3.64e-05	0.000487	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTM1—kidney cancer	3.63e-05	0.000486	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC5A5—kidney cancer	3.63e-05	0.000485	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.61e-05	0.000483	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPC3—kidney cancer	3.59e-05	0.00048	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPC3—kidney cancer	3.57e-05	0.000477	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.56e-05	0.000477	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP1A1—kidney cancer	3.55e-05	0.000475	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA2—kidney cancer	3.5e-05	0.000468	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC2A1—kidney cancer	3.5e-05	0.000468	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA2—kidney cancer	3.49e-05	0.000467	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.48e-05	0.000466	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA2—kidney cancer	3.47e-05	0.000464	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP1A1—kidney cancer	3.44e-05	0.00046	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CTNNB1—kidney cancer	3.4e-05	0.000455	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALAD—kidney cancer	3.4e-05	0.000455	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.4e-05	0.000454	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALAD—kidney cancer	3.38e-05	0.000452	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.37e-05	0.00045	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.36e-05	0.00045	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.35e-05	0.000449	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ST3GAL2—kidney cancer	3.32e-05	0.000444	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ACHE—kidney cancer	3.32e-05	0.000444	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTT1—kidney cancer	3.32e-05	0.000444	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ST3GAL2—kidney cancer	3.3e-05	0.000441	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDH1A1—kidney cancer	3.24e-05	0.000434	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDH1A1—kidney cancer	3.23e-05	0.000431	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACY1—kidney cancer	3.18e-05	0.000425	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IGF2—kidney cancer	3.15e-05	0.000422	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SCARB1—kidney cancer	3.14e-05	0.00042	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC5A3—kidney cancer	3.11e-05	0.000416	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PGK1—kidney cancer	3.11e-05	0.000416	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS1—kidney cancer	3.11e-05	0.000416	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PGK1—kidney cancer	3.09e-05	0.000414	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC5A3—kidney cancer	3.09e-05	0.000414	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LDHB—kidney cancer	3.05e-05	0.000408	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PSMD7—kidney cancer	3.05e-05	0.000408	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LDHB—kidney cancer	3.03e-05	0.000406	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.02e-05	0.000404	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—kidney cancer	3e-05	0.000401	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.96e-05	0.000396	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—kidney cancer	2.93e-05	0.000392	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTP1—kidney cancer	2.92e-05	0.000391	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—BCHE—kidney cancer	2.89e-05	0.000387	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC5A5—kidney cancer	2.86e-05	0.000382	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK3—kidney cancer	2.83e-05	0.000379	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ABCB1—kidney cancer	2.76e-05	0.00037	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC2A1—kidney cancer	2.76e-05	0.000369	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PDHB—kidney cancer	2.7e-05	0.000361	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK1—kidney cancer	2.7e-05	0.000361	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—POMC—kidney cancer	2.69e-05	0.00036	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTM1—kidney cancer	2.68e-05	0.000359	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.68e-05	0.000358	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.66e-05	0.000355	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—POMC—kidney cancer	2.65e-05	0.000354	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA9—kidney cancer	2.64e-05	0.000354	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA9—kidney cancer	2.63e-05	0.000352	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.63e-05	0.000352	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.59e-05	0.000346	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.57e-05	0.000344	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—POMC—kidney cancer	2.57e-05	0.000343	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.57e-05	0.000343	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—kidney cancer	2.55e-05	0.000341	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1A1—kidney cancer	2.54e-05	0.00034	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CCBL1—kidney cancer	2.54e-05	0.00034	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.43e-05	0.000325	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.33e-05	0.000312	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.31e-05	0.000309	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTP1—kidney cancer	2.3e-05	0.000308	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CRABP1—kidney cancer	2.25e-05	0.000301	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CRABP1—kidney cancer	2.24e-05	0.000299	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.2e-05	0.000295	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPAT—kidney cancer	2.2e-05	0.000295	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—kidney cancer	2.18e-05	0.000291	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—kidney cancer	2.11e-05	0.000283	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—kidney cancer	2.11e-05	0.000282	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ITPR2—kidney cancer	2.09e-05	0.00028	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.09e-05	0.00028	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ITPR2—kidney cancer	2.08e-05	0.000278	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FH—kidney cancer	2.05e-05	0.000274	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APRT—kidney cancer	2.05e-05	0.000274	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—kidney cancer	2.05e-05	0.000274	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2e-05	0.000268	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1A1—kidney cancer	2e-05	0.000268	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.93e-05	0.000258	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPC3—kidney cancer	1.93e-05	0.000258	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.92e-05	0.000256	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ACHE—kidney cancer	1.91e-05	0.000255	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTT1—kidney cancer	1.91e-05	0.000255	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—kidney cancer	1.9e-05	0.000254	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ACHE—kidney cancer	1.9e-05	0.000253	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTT1—kidney cancer	1.9e-05	0.000253	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA2—kidney cancer	1.87e-05	0.00025	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—kidney cancer	1.84e-05	0.000246	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALAD—kidney cancer	1.83e-05	0.000244	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SCARB1—kidney cancer	1.8e-05	0.000241	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SCARB1—kidney cancer	1.79e-05	0.00024	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS1—kidney cancer	1.79e-05	0.000239	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—kidney cancer	1.79e-05	0.000239	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.78e-05	0.000238	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS1—kidney cancer	1.78e-05	0.000238	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSMD7—kidney cancer	1.75e-05	0.000234	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSMD7—kidney cancer	1.74e-05	0.000233	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.74e-05	0.000233	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAF1—kidney cancer	1.74e-05	0.000232	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.67e-05	0.000223	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PGK1—kidney cancer	1.67e-05	0.000223	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BCHE—kidney cancer	1.66e-05	0.000222	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BCHE—kidney cancer	1.65e-05	0.000221	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.65e-05	0.00022	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000219	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LDHB—kidney cancer	1.64e-05	0.000219	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC5A5—kidney cancer	1.63e-05	0.000218	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000212	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000211	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—kidney cancer	1.56e-05	0.000208	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.54e-05	0.000206	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.53e-05	0.000204	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—kidney cancer	1.51e-05	0.000202	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.5e-05	0.000201	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—kidney cancer	1.49e-05	0.0002	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—kidney cancer	1.45e-05	0.000194	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA9—kidney cancer	1.42e-05	0.00019	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—kidney cancer	1.41e-05	0.000189	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.34e-05	0.000179	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.33e-05	0.000178	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—kidney cancer	1.32e-05	0.000177	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTP1—kidney cancer	1.32e-05	0.000177	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—kidney cancer	1.32e-05	0.000176	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTP1—kidney cancer	1.31e-05	0.000176	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—kidney cancer	1.3e-05	0.000174	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—kidney cancer	1.26e-05	0.000168	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—kidney cancer	1.25e-05	0.000167	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000167	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—kidney cancer	1.24e-05	0.000166	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000162	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000161	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.21e-05	0.000161	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—kidney cancer	1.19e-05	0.000159	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—kidney cancer	1.19e-05	0.000159	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000154	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1A1—kidney cancer	1.14e-05	0.000153	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—kidney cancer	1.12e-05	0.00015	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.12e-05	0.00015	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—kidney cancer	1.04e-05	0.000139	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—kidney cancer	1.03e-05	0.000138	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACHE—kidney cancer	1.02e-05	0.000137	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTT1—kidney cancer	1.02e-05	0.000137	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—kidney cancer	9.99e-06	0.000134	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SCARB1—kidney cancer	9.69e-06	0.00013	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS1—kidney cancer	9.59e-06	0.000128	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.46e-06	0.000126	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.4e-06	0.000126	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSMD7—kidney cancer	9.4e-06	0.000126	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—kidney cancer	9.31e-06	0.000124	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BCHE—kidney cancer	8.91e-06	0.000119	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.81e-06	0.000118	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—kidney cancer	8.58e-06	0.000115	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—kidney cancer	8.53e-06	0.000114	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.5e-06	0.000114	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—kidney cancer	7.33e-06	9.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTP1—kidney cancer	7.09e-06	9.49e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—kidney cancer	6.85e-06	9.16e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—kidney cancer	6.81e-06	9.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—kidney cancer	6.71e-06	8.98e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—kidney cancer	6.52e-06	8.72e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.18e-06	8.26e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—kidney cancer	5.97e-06	7.98e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—kidney cancer	5.94e-06	7.94e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—kidney cancer	4.61e-06	6.16e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—kidney cancer	4.21e-06	5.63e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—kidney cancer	4.19e-06	5.6e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—kidney cancer	3.67e-06	4.91e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—kidney cancer	3.2e-06	4.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.26e-06	3.02e-05	CbGpPWpGaD
